Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionDr Reddy’s revs up product launches after costs recalibration, execution key

    Dr Reddy’s revs up product launches after costs recalibration, execution key

    New product launch momentum is gathering pace at Dr Reddy’s Laboratories with the company targeting to introduce 30 drugs in the US this fiscal. While the company is also working on COVID-19 medicines, success is contingent on positive research outcomes

    R. Sree Ram
    October 30, 2020 / 08:52 IST
    • PRO Panorama

      Moneycontrol Pro Panorama | Will silver continue to sparkle in 2026?

      Dec 18, 2025 / 02:35 PM IST

      For Moneycontrol's Pro Panorama December 18 edition: India updates stockbroker regulations, Europe’s policy impacts Indian steel...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts